InvestorsHub Logo
Followers 38
Posts 2912
Boards Moderated 0
Alias Born 06/05/2012

Re: Aries post# 21056

Wednesday, 10/29/2014 1:32:28 PM

Wednesday, October 29, 2014 1:32:28 PM

Post# of 30990
What "phase" would this study be under the FDA guidelines? I would guess Phase 1b. But could it possibly be a Phase 2a?

I am (to remedy the situation of current takers) encouraging the co. to immediately start another IND/clinical trial that would invite participation by all previous takers via the supplement route, ostensibly to keep track of both reported benefits and safety for the long term.

I was worried about the cost of such a study, but it turns out that there is no reason why the company could not only avoid bearing the cost, but could actually profit from such a study. Though it is seldom done, the company is not prohibited from charging for study participation.

It appears to be the only fair and legal thing they can do to continue to provide support to those (like me) who depend heavily on anatabine citrate for quality of life issues, and even for life itself. I presume such a study could start in a few months if really pressed ... and they certainly should. - Izof

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.